Topiramate-induced bilateral anterior uveitis associated with hypopyon formation

Ocular Immunology and Inflammation

Volumn 19, Issue 1, 2011, Pages 86-88

  Jabbarpoor Bonyadi, Mohammad Hossein ^a   Soheilian, Roham ^b   Soheilian, Masoud ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

drug induced uveitis; hypopyon; topiramate

Indexed keywords

ATROPINE; BRIMONIDINE; MANNITOL; PREDNISOLONE; TIMOLOL; TOPIRAMATE;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CATARACT; CLOSED ANGLE GLAUCOMA; CORNEA EDEMA; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ECHOOCULOGRAPHY; EYE PAIN; FEMALE; HUMAN; HYPOPYON; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LENS IMPLANTATION; MIGRAINE; MYOPIA; SLIT LAMP; UVEITIS; VISUAL ACUITY;

ADULT; ANTICONVULSANTS; CATARACT; EYE PAIN; FEMALE; FRUCTOSE; GLAUCOMA; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MIGRAINE DISORDERS; OCULAR HYPERTENSION; PHACOEMULSIFICATION; UVEITIS, ANTERIOR; VISUAL ACUITY;

EID: 79952830560     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.523805     Document Type: Article

References (7)

1. Arnone, D. Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiat. 2005;4 (1): 5.
2. Thambi L, Kapcala LP, Chambers W, et al. Topiramateassociated secondary angle-closure glaucoma: a case series. Arch Ophthalmol. 2002;120:1108. (Pubitemid 34856090)
3. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramateassociated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004;111:109-111. (Pubitemid 38032217)
4. Tilden ME, Rosenbaum JT, Fraunfelder FT. Systemic sulfonamides as a cause of bilateral, anterior uveitis. Arch Ophthalmol. 1991;109:67-69.
5. Schnyder B, Pichler WJ. Mechanisms of drug-induced allergy Mayo Clin Proc 2009;84(3):268-272.
6. Krieg PH, Schipper I. Drug-induced ciliary body oedema: a new theory. Eye. 1996;10:121-126. (Pubitemid 26086023)
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. (Pubitemid 12149145)